Italy· 045789029
ELEBRATO ELLIPTA*polv inal 30 dosi 92 mcg + 55 mcg + 22 mcg
A medicinal product containing vilanterolo/umeclidinio/fluticasone, registered in Italy by GLAXOSMITHKLINE TRAD.SERV.LTD, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Vilanterolo/umeclidinio/fluticasone
- Manufacturer
- GLAXOSMITHKLINE TRAD.SERV.LTD
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic045789029ELEBRATO ELLIPTA*polv inal 30 dosi 92 mcg + 55 mcg + 22 mcgEUR 81.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6b26fcf-0842-4653-961d-da9442b26dae GET /v1/drugs/c6b26fcf-0842-4653-961d-da9442b26dae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 81.55,
"source": "aifa",
"currency": "EUR",
"strength": "FLUTICASONE+UMECLIDINIO+VILANTEROLO 92+55+22MCG 30 DOSI USO INALATORIO",
"substance": "Vilanterolo/umeclidinio/fluticasone",
"equivalence_group": "KPM",
"transparency_flag": null
}See everything about vilanterolo/umeclidinio/fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.